The introduction of the 750mcg teriparatide injection in Australia has seen restricted sales to date. Primarily directed for patients with severe osteoporosis who have not responded to other therapies , access is selectively managed. Existing supply quantities are constrained , and patients should verify with their doctor the recent information … Read More